{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:52:13Z","timestamp":1753883533427,"version":"3.41.2"},"reference-count":9,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIA","award":["R01AG052697"],"award-info":[{"award-number":["R01AG052697"]}]},{"name":"San Antonio Claude D. Pepper Older Americans Independence Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypercalcemia of malignancy (HCM) is a common complication seen in patients with cancer and is associated with high morbidity and mortality. Current long-term medical therapy for HCM focuses on inhibiting bone resorption with bisphosphonates or denosumab, which have the rare complication of osteonecrosis of the jaw. This case illustrates cinacalcet as an effective therapy for severe HCM resulting from PTH-related peptide in the setting of osteonecrosis of the jaw. Although the mechanism of action remains unclear, cinacalcet has been successful in other HCM cases even if not associated with elevated PTH-related peptide.<\/jats:p>","DOI":"10.1210\/jcemcr\/luad105","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T08:36:11Z","timestamp":1693643771000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypercalcemia of Malignancy Complicated by Osteonecrosis of the Jaw Treated With Cinacalcet"],"prefix":"10.1210","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2857-4852","authenticated-orcid":false,"given":"Libia","family":"Vasquez","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, University of Texas Health Science Center at San Antonio , San Antonio, TX 78229"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-9542","authenticated-orcid":false,"given":"Tiffany","family":"Cortes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, University of Texas Health Science Center at San Antonio , San Antonio, TX 78229"},{"name":"Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio , San Antonio, TX 78229 , USA"},{"name":"Geriatric Research, Education, and Clinical Center, South Texas Veterans Health Care System , San Antonio, TX 78229 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"issue":"5","key":"2023102813280629000_luad105-B1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner","year":"2016","journal-title":"J Oncol Pract"},{"author":"Bringhurst","key":"2023102813280629000_luad105-B2"},{"issue":"3","key":"2023102813280629000_luad105-B3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/clinem\/dgac621","article-title":"Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline","volume":"108","author":"El-Hajj Fuleihan","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023102813280629000_luad105-B4","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-20-0487","article-title":"Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift","volume":"10","author":"O\u2019Callaghan","year":"2021","journal-title":"Endocr Connect"},{"key":"2023102813280629000_luad105-B5","doi-asserted-by":"crossref","first-page":"110149","DOI":"10.1016\/j.mehy.2020.110149","article-title":"Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy","volume":"143","author":"Sheehan","year":"2020","journal-title":"Med Hypotheses"},{"issue":"2","key":"2023102813280629000_luad105-B6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003495-200565020-00007","article-title":"Cinacalcet hydrochloride","volume":"66","author":"Balfour","year":"2005","journal-title":"Drugs"},{"issue":"1\u20133","key":"2023102813280629000_luad105-B7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2013.04.013","article-title":"Cinacalcet attenuates hypercalcemia observed in mice bearing either rice H-500 Leydig cell or C26-DCT colon tumors","volume":"712","author":"Colloton","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2023102813280629000_luad105-B8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000506100","article-title":"Cinacalcet for the treatment of humoral hypercalcemia of malignancy: an introductory case report with a pathophysiologic and therapeutic review","volume":"13","author":"Sheehan","year":"2020","journal-title":"Case Rep Oncol"},{"key":"2023102813280629000_luad105-B9","first-page":"17","article-title":"Hypercalcemia of malignancy treated with cinacalcet","volume":"2017","author":"Asonitis","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/1\/5\/luad105\/51825231\/luad105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/1\/5\/luad105\/51825231\/luad105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:28:24Z","timestamp":1698499704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luad105\/7258866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luad105","relation":{},"ISSN":["2755-1520"],"issn-type":[{"type":"electronic","value":"2755-1520"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,9,1]]},"article-number":"luad105"}}